Ghp Investment Advisors, Inc. Astrazeneca PLC Transaction History
Ghp Investment Advisors, Inc.
- $2.12 Billion
- Q4 2024
A detailed history of Ghp Investment Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Ghp Investment Advisors, Inc. holds 300 shares of AZN stock, worth $22,695. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 449
33.18%
Holding current value
$22,695
Previous $34,000
44.12%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.57 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.1 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.84 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.8 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.82 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...